로딩 중…
지수 로딩 중…
NeopharmCO.,LTD.
092730· KOSDAQ· Consumer Staples· Household & Personal Products
₩16,970-3.19%
2026-06-19
Price Chart
NeopharmCO.,LTD.+14.97%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 271.99B KRW |
| Revenue | 136.80B KRW |
| Net Income | 8.25B KRW |
| Total Assets | 225.35B KRW |
| Net Assets | 192.11B KRW |
| Employees | 171 |
| Value | |
| P/E | 32.98x |
| P/B | 1.42x |
| PEG | 1.58x |
| P/S | 1.99x |
| EV/EBITDA | 29.63x |
| FCF Yield | 10.01% |
| Profitability | |
| ROE | 4.29% |
| ROA | 3.66% |
| Op. Margin | 5.95% |
| Revenue Growth | 14.60% |
| Earnings Growth | 20.84% |
| Financial Health | |
| Debt Ratio | 117.31% |
| Total Debt | 1.06B KRW |
| FCF | 27.23B KRW |
| Cash | 31.92B KRW |
| Current Ratio | 5.75x |
| Net Debt/EBITDA | -3.79x |
| Dividend | |
| Div. Yield | 4.28% |
| Div. Growth | 25.00% |
| Performance | |
| 1Y Return | 14.97% |
| 1M Return | -6.24% |
| From 52W High | -25.08% |
| 1Y MDD | -25.87% |
| Trading | |
| Volume | 35,828 shares |
| Foreign Own. | 26.11% |
| Per Share | |
| EPS | 1,829 KRW |
| BPS | 12,282 KRW |
Company Info
Established in 2000, the company is a KOSDAQ-listed cosmetics manufacturer. Its largest shareholder became It's Hanbul after the 2017 merger of Hanbul Cosmetics and It's Skin. The company owns cosmetic brands such as Atopalm, Real Barrier, Derma:B, Tl's, and Zeroid, with 83% domestic sales and 17% exports. Utilizing its proprietary MLE formulation technology, it develops products by understanding skin barrier function and expands its business through new formulation development. Neopharm is headquartered in Yuseong-gu, Daejeon.